MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,778 Cr | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr | ₹858 Cr |
What is the latest Total Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,778 Cr |
| Mar2024 | ₹1,293 Cr |
| Mar2023 | ₹1,110 Cr |
| Mar2022 | ₹1,070 Cr |
| Mar2021 | ₹858 Cr |
How is Total Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,778 Cr | 37.50 | |
| Mar2024 | ₹1,293 Cr | 16.45 | |
| Mar2023 | ₹1,110 Cr | 3.78 | |
| Mar2022 | ₹1,070 Cr | 24.69 | |
| Mar2021 | ₹858 Cr | - | |
Compare Total Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹3,332.4 Cr | -0.6% | 16.3% | -3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -0.6% |
16.3% |
-3% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses